Lexicon Pharmaceuticals DSO Ratio 2011-2026 | LXRX

Annual DSO Ratio Lexicon Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.5	26.3	157	55.1	250	433	64.1	34.2	19.5	32.8	2.56	16.5	130	462	69.1

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
462	2.56	118

Quarterly DSO Ratio Lexicon Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
14.5	78.4	1.84 K	-	144	115	74.5	282	136	549	-	45.6	48.2	-	-	361	50.7	838	-	5.43	3.93	325	591	9.62	293	151	31.7	77.6	39.2	19.3	13.3	16.3	36.5	30.7	29.7	24.7	34	30.7	0.65	147	221	49.5	4.4	225	140	301	51.1	303	337	275	577	338	632	263	93.1	90	57.5	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.84 K	0.65	201

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	70.9	$ 19.68	0.92 %	$ 920 M	USA
Amarin Corporation plc AMRN	213	$ 14.5	0.03 %	$ 6.02 B	Irlanda
GlaxoSmithKline plc GSK	0.0222	$ 52.37	1.02 %	$ 173 B	Britain
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 221.59	-0.13 %	$ 5 B	Danmark
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Heron Therapeutics HRTX	198	$ 0.81	3.74 %	$ 135 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Benitec Biopharma BNTC	141	$ 11.05	0.64 %	$ 455 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Incyte Corporation INCY	66.6	$ 90.36	-0.47 %	$ 17.6 B	USA
InMed Pharmaceuticals INM	3.83	$ 0.74	-9.75 %	$ 1.81 M	Canada
INmune Bio INMB	60.1 K	$ 1.17	-0.43 %	$ 21 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	60.8	$ 2.13	1.91 %	$ 199 M	Israel
Arbutus Biopharma Corporation ABUS	31.5	$ 4.43	4.6 %	$ 735 M	Canada